JSR Corporation (JSCPY)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 10, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	5,245	5,927	4,861	6,377	6,458	3,886
Market Cap Growth	21.93%	21.93%	-23.77%	-1.25%	66.17%	13.66%
Enterprise Value	6,077	6,925	5,540	7,031	7,129	4,438
Last Close Price	25.26	28.55	23.42	29.65	30.05	18.10
PE Ratio	-	-161.49	41.25	20.75	-12.95	18.69
PS Ratio	1.96	2.22	1.58	2.27	1.60	0.89
PB Ratio	2.11	2.23	1.70	1.87	1.93	0.96
P/FCF Ratio	-	47.30	-334.48	-26.39	47.00	40.69
P/OCF Ratio	-	14.94	22.08	42.38	10.14	7.71
EV/Sales Ratio	2.27	2.59	1.80	2.50	1.77	1.01
EV/EBITDA Ratio	22.96	26.22	12.07	14.13	14.05	7.79
EV/EBIT Ratio	140.98	162.99	22.59	22.51	29.59	13.66
EV/FCF Ratio	48.49	55.26	-381.19	-29.10	51.88	46.47
Debt / Equity Ratio	0.50	0.50	0.46	0.33	0.38	0.23
Debt / EBITDA Ratio	5.00	5.00	2.90	2.27	2.52	1.66
Debt / FCF Ratio	10.54	10.54	-91.63	-4.67	9.32	9.88
Asset Turnover	0.54	0.54	0.54	0.46	0.66	0.69
Inventory Turnover	2.43	2.43	2.38	2.05	2.88	2.88
Quick Ratio	0.92	0.92	0.93	0.77	1.29	1.23
Current Ratio	1.44	1.44	1.65	2.53	1.95	2.08
Return on Equity (ROE)	-1.14%	-1.14%	4.13%	9.46%	-13.49%	5.87%
Return on Assets (ROA)	0.54%	0.54%	2.67%	3.20%	2.47%	3.19%
Return on Capital (ROIC)	0.69%	0.69%	3.67%	4.45%	3.17%	4.10%
Earnings Yield	-	-0.62%	2.44%	4.82%	-7.72%	5.41%
FCF Yield	-	2.11%	-0.30%	-3.79%	2.13%	2.46%
Dividend Yield	-	-	2.25%	1.94%	1.81%	3.08%
Payout Ratio	-	-	93.71%	37.46%	-	57.74%
Buyback Yield / Dilution	0.74%	0.74%	2.86%	-0.22%	0.97%	2.20%
Total Shareholder Return	0.74%	0.74%	5.11%	1.73%	2.78%	5.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.